WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 5'5501 Infant (under 12 months) mortality rate: 272
GDP / capita (US$): 14'8951 Child (under 5 years) mortality rate: 322

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 37'203  36'116  35'006  33'883  32'777  23'565  17'469  13'653 
Births 1'232  1'212  1'189  1'165  1'140  839  664  545 
Surviving infants 1'197  1'175  1'153  1'129  1'103  809  638  518 
Pop. less than 5 years 5'738  5'603  5'472  5'329  5'177  3'841  2'999  2'435 
Pop. less than 15 years 15'081  14'685  14'306  13'920  13'539  10'121  8'011  6'395 
Female 15-49 years 9'074  8'818  8'537  8'245  7'951  5'604  3'834  2'793 

Number of reported cases

(Click for retrospective incidence data for Iraq)
Diphtheria
ChartChart
  34  10  1'122 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  37  1'433  1'317  669  15  726  3'045  26'542 
Mumps
ChartChart
  73'939  12'957  1'295  1'809  1'482  18'720 
Pertussis
ChartChart
  1'014  529  1'606  2'471  2'314  407  122  16'687 
Polio*
ChartChart
  56  997 
Rubella
ChartChart
  30  22  1'612 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  10  11  37  152  891 
Tetanus (total)**
ChartChart
  31  34  34  1'045 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Iraq)
Vaccine year result method % card seen                                                
BCG 2010  90  MICS   70  90  80  91  93  99*  79  95  76 
DTP1 2010  86  MICS   70  69  80  84  89  95  92  91 
DTP3 2010  70  MICS   70  73  68  74  78  79  86  83  13 
DTP4          70  59 
IPV1         
HepB_BD          47  43  43  43  37  79 
HepB3 2010  66  MICS   70  73  68  74  78  73  67 
Hib3          73  68  74  78  46 
JapEnc         
MCV1          80  71  71  77  83  93  83  35 
MCV2          78  76  76  71  82 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2010  76  MICS   70  77  72  76  79  79  86  83  16 
Rota1          64  55  60  68  65 
RotaC          34  51  52  31 
RCV1          80  76  76  71  82 
TT2plus 2010  29  MICS   70  46  34  49  59  66  55  63 
PAB          21  29  16  48  39 
VAD1          78  59  60  67  17  49 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Iraq)
BCG
ChartChart
  94  84  95  97  95  93  96  76 
DTP1
ChartChart
  73  73  77  82  87  92  93  36 
DTP3
ChartChart
  63  58  64  68  69  80  83  14 
HepB3
ChartChart
  61  56  62  66  61  67 
HepB_BD
ChartChart
  47  43  43  43  37 
Hib3
ChartChart
  63  58  64  68  36 
MCV1
ChartChart
  66  57  57  63  69  86  75 
MCV2
ChartChart
  64  62  60  57  68 
PCV3
 
Pol3
ChartChart
  68  63  67  70  70  83  83  16 
RCV1
ChartChart
  64  62  60  57  68 
RotaC
ChartChart
  34  34  29  52  31 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 137  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
92 
   
/
|
|
\
Greater or equal to 90% 22
From 80 to 89% 20
From 50 to 79% 30
Less than 50% 18
Proportion of districts
not reporting DTP3 coverage
10
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1 week; Yes <12 months
DTaPHibHepIPV 2, 4, 6 months; Yes
DTwPHibHepB 2, 6 months; Yes
DTwPHibIPV 18 months; Yes
HepB birth; Yes
Influenza 6 months - 2 years; above 50 years; Yes Children, elderly, chronic illness, pregnant women, health care workers, Haj or other travellers
Measles 9 months; Yes
MMR 15 months; 4-6 years; Yes
OPV birth; 2, 4, 6, 18 months; 4-6 years; Yes
Pneumo_conj No High risk group
Rotavirus 2, 4, months; Yes
Td >6 years; Yes CBAW
TT 1st contact; +1, +6 months; +1, +1 years; Yes CBAW
Typhoid Yes high risk adults
VitaminA 9, 18 months; 4-6 years;
YF Yes immigrants to africa

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2017-2022  2013-2017  2012-2017  2012-2017  2012-2017  2010-2014  2009-2014 
Nº of districts with microplans that include activities to raise immunization coverage number   135  135  133    129   

System performance

Total Nº districts in country number 137  135  135  133  130  129  125 
Nº districts with DTP3 coverage >=80% number 58  49  54  68  65  98  73 
% of districts with DTP3 coverage >=80% From 0 to 100% 42  36  40  51  50  76  58 
Nº districts with measles (MCV1) coverage >=95% number 27  23  21  15  23  37  39 
% of districts with MCV1 coverage >=95% From 0 to 100% 20  17  16  11  18  29  31 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  Yes  Yes  No   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 99  100  90  100       

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.